Peptide-based immunotherapy of systemic lupus erythematosus (Q35661224)

9 August 2017

1 reference

title

Peptide-based immunotherapy of systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

9 August 2017

1 reference

0 references

author name string

Fanny Monneaux

series ordinal

1

1 reference

9 August 2017

Sylviane Muller

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

16-24

1 reference

Treatment of systemic lupus erythematosus

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Novel approaches to therapy for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Damage in systemic lupus erythematosus and its association with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

The potential use of peptides and vaccination to treat systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Major peptide autoepitopes for nucleosome-specific T cells of human lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Mapping of linear histone regions exposed at the surface of the nucleosome in solution

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are the dominant target of T cell immunity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4(+) T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

T cell epitope mapping of U1-A RNP

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

MHC class II-bound self peptides from autoimmune MRL/lpr mice reveal potential T cell epitopes for autoantibody production in murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Histone peptide-induced nasal tolerance: suppression of murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

A peptide derived from a polyreactive monoclonal anti-DNA natural antibody can modulate lupus development in (NZBxNZW)F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Tolerance induction with agonist peptides recognized by autoaggressive lymphocytes is transient: therapeutic potential for type 1 diabetes is limited and depends on time-point of administration, choice of epitope and adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

IL-10 regulates murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Insights into autoimmunity gained from structural analysis of MHC-peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900061-2

7 January 2021

10.1016/S1568-9972(03)00061-2

Identifiers

DOI

1 reference

9 August 2017

1 reference